loader
Page is loading...
Print Logo Logo
Computer_detail

Media Mentions

Cassava Sciences: Phase III Trials Storm Ahead Amid Controversy

David Slovick was quoted in a Clinical Trials Arena article, “Cassava Sciences: Phase III Trials Storm Ahead Amid Controversy,” regarding recent charges filed by the Securities and Exchange Commission related to misleading statements made in September 2020 by Cassava Sciences. 

RELATED ARTICLES

Subscribe

Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.

View Subscription Center
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.